Progressive Therapeutics is categorized under Physical Examination and Testing Services in Valparaiso, IN .
Progressive Therapeutics was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Examination and Testing Services business, which does work in the B2C market, and is classified as a Physical Examination and Testing Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Adel Baghdady at the company’s single location by writing to 2500 Calumet Avenue # B, Valparaiso, Indiana IN 46383 or by phoning (219) 531-2002. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Progressive Therapeutics |
| Contact Person: | Adel Baghdady |
| Address: | 2500 Calumet Avenue # B, Valparaiso, Indiana 46383 |
| Phone Number: | (219) 531-2002 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Examination and Testing Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Progressive Therapeutics was started in 0 to provide professional Physical Examination and Testing Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Adel Baghdady for inquiries that concern Progressive Therapeutics by calling the company number (219) 531-2002, as your correspondence is most welcome. Additionally, the physical location of the single location of Progressive Therapeutics can be found at the coordinates as well as the street address 2500 Calumet Avenue # B in Valparaiso, Indiana 46383.
For its online presence, you may visit Progressive Therapeutics’s website at and engage with its social media outlets through on Twitter and on Facebook.